Advertisement

Abbott continues to defend long-time executive and new pharmaceutical spin-out chief Richard Gonzalez amid a resume controversy.

fired/hired

 Abbott CEO "fully confident" in future pharma spin-out chief, despite resume fuss
Abbott (NYSE:ABT) chairman & CEO Miles White said he's "fully confident" in Richard Gonzalez as the new head of the company's AbbVie pharmaceutical spin-out, in spite of the ongoing kerfuffle over Gonzalez's "misstated" college credentials.

 The healthcare giant confirmed last week that regulatory filings and company documents had mistakenly attributed to Gonzalez bachelor's and master's degrees, when the long-time Abbott executive never finished college.

Advertisement
Advertisement